Sven Ante Lundberg - Mar 25, 2024 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QTTB	Stock Option (Right to Buy)	Award	$0	+12.8K		$0.00	12.8K	Mar 25, 2024	Common Stock	12.8K	$16.82	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.